A Collaborative Practice Agreement (CPA) is a legal document in the United States that establishes a legal relationship between clinical pharmacists and cooperating physicians, which allows pharmacists to participate in collaborative drug therapy management (CDTM). And while your state may not legally require this contractual agreement, you might need to create a contract to formalize your relationship with any doctor you work with. You can do this to outline different responsibilities and continue to protect yourself and your business. What medications and devices will you prescribe at each training ground? You can list by certain medications or categories of drugs. A detailed description of the categories of drugs and equipment to treat the most common health problems in your particular practice can be developed. For example: categories of drugs such as anti-Semites, oral hypoglycemic drugs/insulin, oral hormones and contraceptives, cephalosporins, aminoglycoids, antivirals, antiasthmatics, diuretics, antihypertensives, etc. may be indicated. Exceptions may be prescribed according to classes of drugs or certain drugs in a class or routes of administration. Set the terms of payment for the doctor`s staff. Most cooperating physicians expect to be paid for their services, with the possible exception of a physician working in a group practice with PRs. Typically, both parties agree on an hourly rate, but annual fees, chart fees, and profit percentages are common agreements.
You and the cooperating doctor can design the compensation structure as you find it pleasant for both parties. What medications, devices, medical treatments, tests and procedures that can be prescribed, ordered and performed could be adapted to the diagnosis and treatment of the most common medical problems in your nursing offices? How is patient counselling and transfer carried out in your practice? The registration of the NAME CPP must be renewed every year and requires 35 hours of continuing education.  According to the PPAC, certified pharmacists are allowed to register for a Personal DeA (Drug Enforcement Administration) number. Their field of activity is mainly general medicine medicinal. Currently, they have prescriptive authority for these three types of diseases: high cholesterol, diabetes and high blood pressure in specific disease management protocols.  In 2015, the American College of Clinical Pharmacy (ACCP) published an updated white paper on collaborative medication management. The CACP regularly publishes updates on this subject, with previous publications in 2003 and 1997. The document describes the recent history of ASAs, legislative progress and discusses payment models for collaborative drug management.  That our WADA develop model national laws to address the extension of the scope of practice of pharmacists, which is inappropriate or constitutes the practice of medicine, including, but not limited to, the issue of the interpretation or use of independent practice agreements, without adequate medical supervision, and cooperation with interested States and disciplines to advance this legislation (Directive on the adoption of Measures).  Your cooperating physician may have a document to use as a starting point.
If not, check with a lawyer or other nurse to see if they have any standard documents to customize for your own use. (Links to the examples below.) And as with any legally binding agreement, you should have the contract checked by a lawyer before signing. What are your minimum standards for consultation between you as a nurse and your primary physician, as in 21 NVC 36.0810 (1) (A) -(B) (2) (3) (A) (C) and 21 NVC 32M (e) (1) (A) -B)) (2) (3) (A) –C)? This Nurse Practitioner/Physician consultation stands out for the new graduate, the new Practitioner Nurse with the first admission to practice in North Carolina compared to a subsequent collaborative practice agreement between a Nurse Practitioner previously admitted to the practice in North Carolina and another senior physician in charge. . . .